Nephrocare Health Services IPO

About Nephrocare Health Services Company

Nephrocare Health Services Ltd., incorporated in 2010 and headquartered in Hyderabad, provides comprehensive end-to-end dialysis care through an extensive network of 490 clinics across 269 cities in 21 Indian states/UTs and international locations including the Philippines, Uzbekistan, and Nepal, with a strong emphasis on tier II/III cities. Starting with its first clinic in Hyderabad, the company has expanded from haemodialysis services to include home/mobile dialysis, diagnosis, wellness programs, in-house pharmacies, and partnerships with major hospital chains like Max Super Speciality, Fortis Escorts, Care Hospitals, Wockhardt, Paras Healthcare, Calcutta Medical Research Institute, Jehangir Hospital, and Ruby Hall Clinic for integrated in-house centers. Its core expertise lies in managing over 5,000 dialysis machines and serving diverse patient needs with standardized protocols, supported by 3,230 medical and administrative staff. Nephrocare's strengths include scalable operations reaching underserved areas, the world's largest single dialysis clinic in Uzbekistan, and a patient-centric model delivering over 2.88 million treatments annually. The company engages stakeholders through reliable service delivery, strategic hospital collaborations, and focus on accessibility to tackle renal care gaps in emerging markets effectively.

Read our in-depth analysis of the Nephrocare Health Services Ltd IPO Here